A common ß1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.

Parvez, Babar; Chopra, Nagesh; Rowan, Shane; Vaglio, Joseph C; Muhammad, Raafia; Roden, Dan M; Darbar, Dawood

Parvez, Babar; Chopra, Nagesh; Rowan, Shane; Vaglio, Joseph C; Muhammad, Raafia; Roden, Dan M; Darbar, Dawood.

Affiliation

Parvez B; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37323, USA.

J Am Coll Cardiol ; 59(1): 49-56, 2012 Jan 03.

Article in En | MEDLINE | ID: mdl-22192668

Subject(s)

Adrenergic beta-1 Receptor Antagonists/therapeutic use; Atrial Fibrillation/drug therapy; Atrial Fibrillation/genetics; Polymorphism, Genetic; Receptors, Adrenergic, beta-1/genetics; Aged; Anti-Arrhythmia Agents/therapeutic use; Atrial Fibrillation/diagnosis; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography/methods; Female; Follow-Up Studies; Heart Rate/drug effects; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prospective Studies; Registries; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Atrial Fibrillation / Receptors, Adrenergic, beta-1 / Adrenergic beta-1 Receptor Antagonists Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google